We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · September 21, 2022

Long-Term Efficacy and Safety of Adjunctive Cenobamate Treatment in Patients With Uncontrolled Focal Seizures

Neurology

 

Additional Info

Neurology
Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Neurology 2022 Sep 06;99(10)e989-e998, P Klein, S Aboumatar, C Brandt, F Dong, GL Krauss, S Mizne, JC Sanchez-Alvarez, BJ Steinhoff, V Villanueva

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading